Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
electroCore's revenue for the
three
months ended in Jun. 2026 was $9.45 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was $36.97 Mil.
electroCore's Revenue per Share for the
three
months ended in Jun. 2026 was $1.01.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was $4.15.
During the past 12 months, the average Revenue per Share Growth Rate of electroCore was 22.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 27.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 26.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 10 years, electroCore's highest 3-Year average Revenue per Share Growth Rate was 265.40% per year. The lowest was 14.20% per year. And the median was 34.50% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
electroCore Revenue Related Terms
electroCore Revenue Historical Data
* Premium members only.
The historical data trend for electroCore's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, electroCore's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
electroCore Revenue vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, electroCore's Revenue distribution charts can be found below:
* The bar in red indicates where electroCore's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $36.97 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
electroCore (ECOR) has a Revenue of $36.97 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on electroCore and its competitors.
Is electroCore's Revenue too high?
electroCore's current Revenue is $36.97 Mil. Overall, electroCore has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does electroCore's Revenue compare to COCH and MDAI?
electroCore's Revenue of $36.97 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on electroCore and its competitors. electroCore's current Revenue is $36.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is electroCore stock overvalued right now?
Based on GuruFocus' analysis, electroCore (ECOR) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.64, compared to a current price of $9.73 — trading 12.6% above its estimated fair value. The current Revenue is $36.97 Mil. electroCore's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For electroCore (ECOR), the current Revenue is $36.97 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is electroCore (ECOR) Overvalued in 2026?
Based on GuruFocus' analysis, electroCore stock appears to be overvalued.
The current stock price of $9.73 is trading 12.6% above its estimated GF Value™ of $8.64.
GuruFocus considers electroCore to be Modestly Overvalued.
Key valuation signals for ECOR:
Revenue: $36.97 Mil
GF Value™: $8.64 vs. price of $9.73 (12.6% above fair value)
No single metric tells the full story. See the ECOR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
76GF Score
Get the complete analysis for ECOR
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ECOR has been successfully added to your 
